Tunitas Therapeutics' Series A Round

Tunitas Therapeutics raised a round of funding on September 30, 2015.

Tunitas Therapeutics is a privately held biopharmaceutical company that is developing novel and precisely targeted protein therapeutics with the potential to dramatically change the lives of allergy s…

Articles about Tunitas Therapeutics' Series A Round: